NPI: 1184202897 · DENVER, CO 80204 · Federally Qualified Health Center (FQHC) · NPI assigned 04/01/2021
Authorized official AUDAIN, APRIL controls 20+ related entities in our dataset. Read more
| Authorized Official | AUDAIN, APRIL (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 04/01/2021 |
Other providers sharing the same authorized official: AUDAIN, APRIL
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 8,211 | $567K |
| 2022 | 25,163 | $3.45M |
| 2023 | 28,704 | $5.21M |
| 2024 | 14,256 | $2.73M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34,564 | 32,033 | $6.14M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 17,146 | 16,133 | $3.68M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12,386 | 11,344 | $1.96M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 883 | 815 | $154K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 648 | 553 | $14K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14 | 13 | $2K |
| 99215 | Prolong outpt/office vis | 28 | 26 | $2K |
| 36415 | Collection of venous blood by venipuncture | 10,588 | 9,830 | $140.92 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 32 | 29 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 32 | 30 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 13 | 12 | $0.00 |